Skip to main content

Table 4 Cytoplasmic REDD1 expression and OS

From: Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma

REDD1 expression No. of patients Median survival months (95% CI) Survival rate (95% CI) χ2 P-value
36-months 60-months 120-months
Low expression 148 125.000(113.914,137.086) 0.76(0.671, 0.828) 0.71(0.007,0.976) 0.33(0.217,0.448) 40.115 < 0.001
High expression 81 32.700(16.536,48.864) 0.41(0.273,0.542) 0.24(0.119,0.384) 0.08(0.017,0.211)